Skip to content

Clinical trials

Phase 2 Hematologic Diseases trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 2 Status: Unknown status Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20122
20133
20142
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanfang Hospital, Southern Medical University4
Institute of Hematology & Blood Diseases Hospital, China3
Hellenic Society of Hematology2
Copenhagen University Hospital at Herlev1
Guangzhou General Hospital of Guangzhou Military Command1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases11
Anemia3
Anemia, Hemolytic3
Anemia, Aplastic2
Blood Protein Disorders2
Bone Marrow Failure Disorders2
Hemoglobinuria2
Hemoglobinuria, Paroxysmal2
Multiple Myeloma2
Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.